Advertisement
Advertisement
U.S. markets close in 1 hour 56 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Qualigen Therapeutics, Inc. (QLGN)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.4300+0.0139 (+3.34%)
As of 01:55PM EDT. Market open.
Advertisement

Qualigen Therapeutics, Inc.

2042 Corte Del Nogal
Carlsbad, CA 92011
United States
760 918 9165
https://www.qualigeninc.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees39

Key Executives

NameTitlePayExercisedYear Born
Mr. Michael S. PoirierChairman & CEO742.28kN/A1956
Ms. Amy S. BroidrickPres, Chief Strategy Officer & Director562.13kN/A1958
Mr. Tariq Arshad M.B.A., M.D.Sr. VP & Chief Medical Officer486.44kN/A1970
Mr. Christopher L. LotzVP of Fin. & CFON/AN/A1965
Mr. Shishir K. SinhaCOO, Corp. Sec. & Sr. VP of DiagnosticsN/AN/A1967
Dr. Wajdi Abdul-AhadVP of R&D and Chief Scientific OfficerN/AN/A1953
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and STARS blood cleansing system, a DNA/RNA-based treatment device that removes tumor-produced compounds and viruses from a patient's blood. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California.

Corporate Governance

Qualigen Therapeutics, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement